Skip to main content
Fig. 1 | Lipids in Health and Disease

Fig. 1

From: Transcatheter arterial chemoembolization combined with Hippo/YAP inhibition significantly improve the survival of rats with transplanted hepatocellular carcinoma

Fig. 1

TACE combined verteporfin reduces the tumor weight of transplanted HCC. Verteporfin improves the effect of TACE in alleviating transplanted HCC. A, Morphology of tumor lesion in different groups. Morphology analysis showed that tissue injuries in the sham, TACE, verteporfin, and TACE+verteporfin groups were gradually lessened. Symptoms in the TACE+verteporfin group was significantly better than those in the TACE group (black arrow: normal tissue, the number of rats showing similar histopathology is 5); B, Tumor weight in different groups. And the tumor weight / body weight rates for 4 groups were 0.0132, 0.1040, 0.0088, 0.0064, respectively. (Results are presented as the mean ± SD, n = 5 per group; Compared with the Sham group, ****P < 0.0001; Compared with the TACE group, ###P < 0.001 and ####P < 0.001)

Back to article page